FDA Adverse Event Injury Summary report: N

LAMITRODE 44

MDR report key: 3960426 · Received July 17, 2014

Report

Report Number
1627487-2014-26568
Event Type
Injury
Date Received
July 17, 2014
Date of Event
June 27, 2014
Report Date
June 27, 2014
Manufacturer
ST. JUDE MEDICAL - NEUROMODULATION
Product Code
GZB
PMA / PMN Number
P010032
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

SJM HAS LIMITED INFORMATION RELATED TO THE PATIENT'S MEDICAL HISTORY AND IS UNABLE TO FORM AN OPINION AS TO THE RELEVANCY OF THE PATIENT'S HISTORY TO THE EVENT REPORTED. SJM DEFERS TO THE PATIENT'S PHYSICIAN REGARDING MEDICAL HISTORY.

Description of Event or Problem · 1

THE PATIENT HAS TWO OCCIPITAL LEADS (FOR OFF-LABEL USE) FROM THE UNKNOWN LOT NUMBER. IT WAS REPORTED THE PATIENT LOST STIMULATION TO HER LEFT SIDE. DIAGNOSTIC TESTING INDICATED INVALID IMPEDANCE READINGS. SURGICAL INTERVENTION WAS UNDERTAKEN ON (B)(6) 2014 AND 1 LEAD WAS FOUND TO BE COILED DOWN AROUND THE IPG. THE LEAD WAS SHEARED AND TORN. THE LEAD WAS EXPLANTED AND REPLACED AND INTRA-OPERATIVE DIAGNOSTICS WERE WITHIN NORMAL LIMITS. HOWEVER, INTRA-OPERATIVE DIAGNOSTICS FOR THE SECOND LEAD INDICATED INVALID IMPEDANCES. X-RAYS DID NOT REVEAL ANY ANOMALIES. POSTOPERATIVE DIAGNOSTICS INDICATED INVALID IMPEDANCES. THE PATIENT WAS TAKEN BACK INTO SURGERY AND THE SECOND LEAD WAS EXPLANTED. INTRA-OPERATIVE DIAGNOSTICS SHOWED IMPEDANCE READINGS WITHIN NORMAL LIMITS. THE PATIENT REPORTED EFFECTIVE STIMULATION COVERAGE POSTOPERATIVE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
420486 LAMITRODE 44 SCS LEAD GZB ST. JUDE MEDICAL - NEUROMODULATION 3254 UNK

Patients

Seq Age Sex Outcome Treatment
1 67 YR Other SCS IPG: MODEL 3788| IMPLANT DATE: